NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Flipper,

I would have to think that the finish line the company would be talking about would be the BLA. The Journal should be Dr. Liau's baby, FlaskWork's belongs to the FlaskWork people. I would hope the update to Clinical Trials is done, just needs to be sent. That leaves the BLA which is really the most important thing the company is working on.

If the BLA is near submission we should understand just how close we may be to the first approval. Everything that seems to be happening in the U.K. makes it sound like it won't take long there, perhaps no more than a month or two.

Of course it's possible that the regulators have agreed to work together on this, and will all approve at once. I believe it would be unusual, but then again, this have been a very unusual trial.

Gary